Top tips for prompting AI – A snapshot from The AI for Medical Affairs Course
Pharma pricing strategy in uncertain times
What good brand planning really looks like - Avoiding common pitfalls
6 Principles of pharmaceutical sales forecasting
Generating clinical evidence for HTA: challenges and solutions
How to build a future-proof AI adoption roadmap in pharma marketing
Omnichannel Budget Planning for the New Normal
The many faces of a full HTA
Selecting the right Medical tactics based on Reach & Impact
Epi-based vs. sales-based forecasting in pharma: a false dichotomy?
Slide Snapshot: Fundamental Partnering Models in Pharma/Biotech
How to Optimise Portfolio Strategy in Pharma for Today AND Tomorrow
Agile Country-level Resource Optimisation Across a Pharma Portfolio & Across Brand Tactics
Your EU5 Market Access acronyms / abbreviations list
6 Domains of Medical Affairs excellence: Unlocking the value of the Medical Affairs role
Unlock the power of the Net Promoter Score (NPS) in pharma
Basics of Health Economics - Online Self-Study Programme: Preview
Recorded Webinar: Pricing and Forecasting Cell and Gene Therapies
Exploring the layers of the pharmaceutical royalty stack
Top tips for setting KPIs for a country pharma launch
7 Key omnichannel marketing objectives and strategies to consider in pharma
What You Should Know About the QALY and About the Value of Health/QALY Gains with New Therapies
Challenges in Valuation: The In-Licensing Perspective
The value dossier and value story
Slide Snapshot: KPI Framework for Omnichannel in Pharma
The difference between ‘professional’ and ‘master’ level negotiation skills in pharma licensing
How Comparative RWE Can Help You with HTA and Payors When No RCT Evidence is Available
10 Practical guidelines for better health economic evaluations
Test your knowledge of pharmaceutical licensing
Driving Lifecycle Management Excellence Across the Full Product Lifecycle
Integrative vs. distributive pharma licensing negotiation strategies
The 5 most useful sales forecasting techniques for pharmaceuticals
A holistic framework for evaluating pharmaceutical in-licensing opportunities
The essence of global-to-local launch activation in pharma
Cost-Effectiveness Analysis vs Budget Impact Analysis
What is a QALY and how to calculate it? – By Prof. Dr. Lieven Annemans
Designing a Strategic KOL Plan for Success
Test your omnichannel knowledge & skills in pharma
Are you correctly forecasting the uptake of your brand(s)?
Slide Snapshot: KPI Framework for Omnichannel in Pharma
Slide Snapshot: Top 5 tips to build effective omnichannel MedEd campaigns
Test your knowledge of pharma market access & payers in Europe
Are you ready for AI in pharma market access?
Why pharma product launches fail, according to Gary Johnson!
What Clinicians and Patients Need (and Want!) to Know About the Value for Money of New Health Innovations
Overview of the different KOL roles across the lifecycle of a product
9,5 steps to a successful Advisory Board Meeting – Do you actually need one?
7 Negotiation skills you need to get the best possible pharma licensing deals
Slide Snapshot: Navigating the landscape of medical insight
Your US market access glossary
How AI Can Streamline Market Access and Reimbursement – From Dossier Writing to Strategic Decision-Making
The in- & out-licensing processes at a glance
Thinking With Data
Mastering pharma licensing negotiations: 6 Rules for a value-based structured approach
Recorded Webinar: How to Set Prices When You Cannot Talk to Payers?
The role of RWE across the product lifecycle
Checklist to Assess Risk Factors & Drivers Impacting Valuation in Pharma/Biotech
The difference between Patient FLOW and Patient JOURNEY
Artificial Intelligence: How Effective is it for Pharma Pricing and Forecasting?
Checklist to assess pharma brand plan insights
Test your understanding of SWOTs
Overview of different valuation approaches in the life science industry
Understanding the interconnected landscape of payer types in the European healthcare environment
Omnichannel transformation: Where’s the industry at?
From Patient Insights to Key Growth Drivers for Pharmaceuticals
The differences between multichannel and omnichannel in pharma
Do you know what a QALY is, and how to calculate it?
Preference scores from conjoint studies can be converted into useful market share estimates
The importance of personas & segmentation for an omnichannel pharma launch
The clinical and non-clinical domains of Health Technology Assessment
Different types of pricing in pharma
Can you forecast the relationship between your level of promotion and your sales?
5 Omnichannel opportunities for biopharma to engage HCPs in the medical space
Do you know the difference between health economic evaluations and Health Technology Assessments?
What is a good Critical Success Factor (or: Strategic Imperative, Key Driver) for your brand in today’s VUCA pharma markets?
Slide Snapshot: Overview of Internal Stakeholder KOL Needs
From Patient Flow & Journeys to CSFs – The best approach
Key Success Criteria for Real-World Evidence (RWE) Studies
7 Powerful negotiation tools used in Pharma Licensing Negotiations
The Pharma Brand Plan Quality Checklist
9,5 steps to a successful Advisory Board Meeting
Test your knowledge of pharma sales forecasting
The 3 key elements to a successful omnichannel launch
4 types of KOL mapping in pharma
Boosting Medical Affairs Impact: Ingredients for Success
Tips for structuring a licensing deal between a biotech and a pharma company
The 10 possible criteria in HTA – 10 tips
The power of medical insights for success in pharma
Slide Snapshot: Payer Archetypes in Europe
Self-assessment test – Basics of Health Economics
What is an excellent launch in pharma?
Medical vs. pharmacy benefits in USA managed care
Preparing for the EU Joint Clinical Assessment HTA Process
3 Main challenges in pharma forecasting
Do you know the key drivers of price sensitivity for pharmaceuticals?
Omnichannel Launch Excellence: only one chance to get it right!
The importance and structure of licensing term sheets in pharma/biotech
The 2 dimensions of health economic evaluations
The anatomy of a medical plan – A guide for medical affairs professionals
How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans
Do you know the answer to this exercise on QALYs?
Commonly misused pricing terms in pharma
Omnichannel engagement: The key to successful pharmaceutical launches
List of acronyms commonly used in RWE
The core omnichannel components of a pharma launch
The case for a smarter early commercialisation strategy when launching a pharma brand
Unlock clarity in pharma pricing: Your go-to glossary for commonly misused terms
The 4 payer types to be considered in optimising value pricing in pharma
The key to Market Access success is cross-functional collaboration
Checklist for evaluating an R&D product prior to out-licensing
Slide Snapshot: Deal types in pharma/biotech
Recorded Webinar: How to Avoid Common Mistakes with Conjoint Analysis in Pharma Market & Pricing Research
How to measure the ROI of your digital campaigns in pharma
4 core MSL competencies: Training priorities for Medical Science Liaisons
Do you have an effective Market Access planning process in place for new brands?
Do you know the 5 categories of payers and their respective roles and drivers?
Is biopharma ready for customer-centric omnichannel?
How Business Development Optimally Contributes to the Pharmaceutical Value Chain
Addressing Real-World Evidence (RWE) challenges in healthcare